[CASE] Novozymes OneHealth: Innovation Journey
Novozymes OneHealth is the human health unit of one of the world’s leading biotech companies. They are doing research into solutions to help improve gut health for the 3 out of 5 people worldwide who struggle with regular digestive problems. And they are driven by a mission that solutions should not only provide relief to a specific problem but also be designed to meet the reality of consumers’ daily life and routines.
Ipsos has helped design and lead Novozymes OneHealth through an innovation journey: First phases uncovering the discomforts people experience and which solutions are more attractive, thus helping Novozymes to re-define market and identify white spaces. Next phases focussing on the development of final concept and to unfold its actual market potential on selected main markets. And, when the final solution is developed, to test brand name, pricing, key messages etc.
For more information, please contact:
Jens Dupont, Director
Phone: +45 2855 8612
Email: [email protected]
